Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is trastuzumab associated with adverse cardiac effects in patients with breast cancer?

Nature Clinical Practice Oncology volume 5, pages 192–193 (2008)Cite this article

boxed-textSuter TM et al. (2007) Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial. J Clin Oncol 25: 3859–3865

Background

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Ewer MS and Lippman SM (2005) Type II chemotherapy related cardiac dysfunction: time to recognize a new entity. J Clin Oncol 23: 2900–2902

    Article  CAS  Google Scholar 

  2. Ewer MS et al. (2005) Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment. J Clin Oncol 23: 7820–7826

    Article  CAS  Google Scholar 

  3. Lenihan DJ et al. (2007) Superior detection of cardiotoxicity during chemotherapy using biomarkers. J Card Failure 13: S151

    Article  Google Scholar 

  4. Cardinale D et al. (2004) Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy. Circulation 109: 2749–2754

    Article  CAS  Google Scholar 

  5. Kalay N et al. (2006) Protective effects of carvedilol against anthracycline-induced cardiomyopathy. J Am Coll Cardiol 48: 2258–2262

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Mandy Aujla, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. MS Ewer is Professor of Medicine and Special Assistant to the Vice President, and DJ Lenihan is Associate Professor of Medicine and Director of Cardiac Clinical Research, at the University of Texas MD Anderson Cancer Center, Houston, TX, USA.,

    Michael S Ewer & Daniel J Lenihan

Authors
  1. Michael S Ewer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel J Lenihan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael S Ewer.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ewer, M., Lenihan, D. Is trastuzumab associated with adverse cardiac effects in patients with breast cancer?. Nat Rev Clin Oncol 5, 192–193 (2008). https://doi.org/10.1038/ncponc1045

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc1045

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing